I was on the SIR discovery from pre-discovery and really felt GAL was a clone.
Considering their FR holdings and the Callisto resource announced, I think the current MC is a little low but probably right in this market.
Disappointed yes, as it's obvious they haven't built on the initial discovery with further ones, so hanging on from pre-discovery price to the highs back to where we are is hard to swallow, but hindsight is so easy to make judgements.
if they did (or do in the future) find further discoveries as expected, then everyone would have been saying you sold out way to cheap.
One drill bit in the right location, assuming more discoveries are there to be made, will see GAL soar again, so I'm sitting on them.
Exploration is risky by nature. Can only back proven management and big investors and hope the planets align. You certainly can't question the ethics of this management like you can with so many ASX specs.
Milesy
- Forums
- ASX - By Stock
- GAL
- Ann: New Mineralised Zones Show Opportunity for Growth
Ann: New Mineralised Zones Show Opportunity for Growth, page-36
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GAL (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.67M |
Open | High | Low | Value | Volume |
13.5¢ | 14.0¢ | 13.5¢ | $17.46K | 129.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 37036 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 150029 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 37036 | 0.135 |
4 | 142692 | 0.130 |
4 | 79991 | 0.125 |
4 | 134669 | 0.120 |
1 | 8500 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 150029 | 3 |
0.145 | 108482 | 4 |
0.150 | 100000 | 1 |
0.155 | 378673 | 2 |
0.170 | 40000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
GAL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online